Nordson Corporation (FRA:ND1)
Germany flag Germany · Delayed Price · Currency is EUR
248.40
-3.70 (-1.47%)
At close: Feb 20, 2026

Revenue

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19 Oct '18 Oct '17 Oct '16 Oct '15 Oct '14 Oct '13 Oct '12
Industrial Precision Solutions Revenue
1.36B1.33B1.40B
Industrial Precision Solutions Revenue Growth
1.98%-4.80%0.56%
Medical and Fluid Solutions Revenue
834.96M835.39M695.45M
Medical and Fluid Solutions Revenue Growth
-0.05%20.12%5.32%
Advanced Technology Solutions Revenue
652.56M624.51M595.56M
Advanced Technology Solutions Revenue Growth
4.49%4.86%3.17%
Advanced Technology Solutions Revenue (Pre-FY2022 Reporting)
1.49B1.46B1.29B
Advanced Technology Solutions Revenue (Pre-FY2022 Reporting) Growth
1.89%13.08%4.32%
Revenue (Total)
2.85B2.79B2.69B
Revenue (Total) Growth
1.94%3.78%2.33%

Revenue by Geography

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19 Oct '18 Oct '17 Oct '16 Oct '15 Oct '14 Oct '13 Oct '12
Americas Revenue
1.20B1.21B1.18B
Americas Revenue Growth
-0.49%2.31%2.51%
Europe Revenue
736.92M722.22M726.10M
Europe Revenue Growth
2.04%-0.53%6.36%
Asia Pacific Revenue
908.89M863.64M785.20M
Asia Pacific Revenue Growth
5.24%9.99%-1.38%
Revenue (Total)
2.85B2.79B2.69B
Revenue (Total) Growth
1.94%3.78%2.33%

EBITDA

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19 Oct '18 Oct '17 Oct '16 Oct '15 Oct '14 Oct '13 Oct '12
Industrial Precision Solutions EBITDA
-493.87M520.77M
Industrial Precision Solutions EBITDA Growth
--5.17%7.33%
Medical and Fluid Solutions EBITDA
-311.68M256.55M
Medical and Fluid Solutions EBITDA Growth
-21.49%4.36%
Advanced Technology Solutions EBITDA
-146.59M129.18M
Advanced Technology Solutions EBITDA Growth
-13.48%-10.74%
Operating Income (Total)
737.18M711.73M674.00M
Operating Income (Total) Growth
3.58%5.60%0.18%

EBIT

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19 Oct '18 Oct '17 Oct '16 Oct '15 Oct '14 Oct '13 Oct '12
Industrial Precision Solutions Operating Profit
--470.56M
Industrial Precision Solutions Operating Profit Growth
--2.10%
Medical and Fluid Solutions Operating Profit
--187.73M
Medical and Fluid Solutions Operating Profit Growth
---0.86%
Advanced Technology Solutions Operating Profit
--94.23M
Advanced Technology Solutions Operating Profit Growth
---7.31%
Advanced Technology Solutions Operating Profit (Pre-FY2022 Reporting)
--281.96M
Advanced Technology Solutions Operating Profit (Pre-FY2022 Reporting) Growth
---3.12%
Corporate Operating Profit
---78.52M
Operating Income (Total)
737.18M711.73M674.00M
Operating Income (Total) Growth
3.58%5.60%0.18%

Key Performance Indicators

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19 Oct '18 Oct '17 Oct '16 Oct '15 Oct '14 Oct '13 Oct '12
Industrial Precision Solutions (IPS) - Organic Revenue Growth
-5.10%0.90%
Medical and Fluid Solutions (MFS) - Organic Revenue Growth
-3.10%-0.20%
Advanced Technology Solutions (ATS) - Organic Revenue Growth
4.10%-11.20%
Total Organic Revenue Growth
-2.50%-2.50%
Updated Jan 31, 2026. Data Source: Fiscal.ai.